Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Mark J Alles. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Mark J Alles har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:SYRS / Syros Pharmaceuticals, Inc. | Director | 3 666 |
US:BMRN / BioMarin Pharmaceutical Inc. | Director | 15 095 |
US:TPTX / Turning Point Therapeutics Inc | Director | 0 |
US:CELG / Celgene Corp. | CEO, CHAIRMAN OF BOARD, Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Mark J Alles. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp SYRS / Syros Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i SYRS / Syros Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2020-05-13 | SYRS | Alles Mark J | 10 000 | 8,8590 | 1 000 | 88,5900 | 88 590 | 251 | 149.5 | 60 910 | 68,75 |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i SYRS / Syros Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Mark J Alles som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-19 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Common Stock |
M - Exercise | 2 666 | 3 666 | 266,60 | ||||
2023-05-24 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 190 | 15 095 | 38,42 | ||||
2022-11-02 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
P - Purchase | 3 625 | 10 905 | 49,79 | 86,75 | 314 469 | 946 009 | |
2022-08-17 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | −2 000 | 0 | −100,00 | 76,00 | −152 000 | ||
2022-05-26 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 4 980 | 7 280 | 216,52 | ||||
2022-01-05 |
|
4 | BMRN |
BIOMARIN PHARMACEUTICAL INC
Common Stock |
A - Award | 2 300 | 2 300 | |||||
2021-06-21 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Common Stock |
P - Purchase | 2 000 | 2 000 | 81,34 | 162 680 | 162 680 | ||
2021-06-10 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2021-06-04 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 209 | 209 | |||||
2021-05-26 |
|
4 | TPTX |
Turning Point Therapeutics, Inc.
Stock Option (right to buy) |
A - Award | 17 000 | 17 000 | |||||
2020-06-11 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2020-05-13 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Common Stock |
P - Purchase | 10 000 | 10 000 | 8,86 | 88 590 | 88 590 | ||
2019-12-20 |
|
4 | SYRS |
Syros Pharmaceuticals, Inc.
Stock Option (right to buy) |
A - Award | 35 000 | 35 000 | |||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −29 669 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −29 669 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −8 625 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −8 625 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −8 625 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −8 625 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −10 175 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −10 175 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −15 670 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −20 350 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −17 738 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −17 738 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −19 688 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −17 738 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −17 738 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −12 488 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −17 500 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −8 326 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −8 326 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −8 326 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −10 994 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | −6 252 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | −366 495 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 74 414 | 366 495 | 25,48 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 45 119 | 292 081 | 18,27 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 25 696 | 246 962 | 11,61 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | −115 755 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted stock Unit |
D - Sale to Issuer | −18 800 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | −30 079 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | −17 131 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −59 234 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −59 234 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −59 234 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −33 881 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −33 881 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −33 881 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −33 880 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −29 669 | 0 | −100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | −29 669 | 0 | −100,00 | ||||
2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −15 608 | 0 | −100,00 | ||||
2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −6 620 | 221 266 | −2,90 | 95,21 | −630 290 | 21 066 736 | |
2019-05-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 15 608 | 227 886 | 7,35 | ||||
2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
M - Exercise | −33 809 | 0 | −100,00 | ||||
2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 115 755 | 115 755 | |||||
2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −13 900 | 212 278 | −6,15 | 85,96 | −1 194 844 | 18 247 417 | |
2019-03-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 33 809 | 226 178 | 17,58 | ||||
2019-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 18 800 | 18 800 | |||||
2019-01-30 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
A - Award | 33 809 | 33 809 | |||||
2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −8 929 | 0 | −100,00 | ||||
2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −3 876 | 192 369 | −1,98 | 68,20 | −264 343 | 13 119 566 | |
2018-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8 929 | 196 245 | 4,77 | ||||
2018-10-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 59 234 | 59 234 | |||||
2018-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 59 234 | 59 234 | |||||
2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 1 208 | 187 316 | 0,65 | 82,60 | 99 784 | 15 472 864 | |
2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 30 079 | 30 079 | |||||
2018-05-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (Right to Buy) |
A - Award | 59 234 | 59 234 | |||||
2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −3 500 | 0 | −100,00 | ||||
2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −1 519 | 186 108 | −0,81 | 86,89 | −131 986 | 16 170 924 | |
2018-05-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 500 | 187 627 | 1,90 | ||||
2018-02-20 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
M - Exercise | −7 283 | 0 | −100,00 | ||||
2018-02-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −2 060 | 184 127 | −1,11 | 95,26 | −196 236 | 17 539 938 | |
2018-02-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 283 | 186 187 | 4,07 | ||||
2018-02-15 |
|
4 | CELG |
CELGENE CORP /DE/
Performance Stock Unit |
A - Award | 7 283 | 7 283 | |||||
2018-02-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 3 260 | 178 904 | 1,86 | 91,90 | 299 594 | 16 441 278 | |
2018-01-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 881 | 33 881 | |||||
2017-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −4 550 | 0 | −100,00 | ||||
2017-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −2 094 | 175 644 | −1,18 | 107,06 | −224 184 | 18 804 447 | |
2017-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 550 | 177 738 | 2,63 | ||||
2017-10-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 881 | 33 881 | |||||
2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 881 | 33 881 | |||||
2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −4 200 | 0 | −100,00 | ||||
2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −1 932 | 173 188 | −1,10 | 134,10 | −259 081 | 23 224 511 | |
2017-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 200 | 175 120 | 2,46 | ||||
2017-05-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 17 131 | 17 131 | |||||
2017-05-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 33 880 | 33 880 | |||||
2017-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −6 643 | 170 920 | −3,74 | 117,02 | −777 364 | 20 001 058 | |
2017-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 14 447 | 177 563 | 8,86 | ||||
2017-01-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
2016-12-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −6 560 | 0 | −100,00 | ||||
2016-12-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −3 018 | 163 116 | −1,82 | 117,63 | −355 007 | 19 187 335 | |
2016-12-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 560 | 166 134 | 4,11 | ||||
2016-11-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
2016-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 15 608 | 15 608 | |||||
2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 29 669 | 29 669 | |||||
2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −11 000 | 0 | −100,00 | ||||
2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −5 062 | 159 574 | −3,07 | 103,41 | −523 461 | 16 501 547 | |
2016-05-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 11 000 | 164 636 | 7,16 | ||||
2016-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −11 889 | 153 636 | −7,18 | 102,45 | −1 218 028 | 15 740 008 | |
2016-02-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 25 840 | 165 525 | 18,50 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 506 | 2 704 | −35,77 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 720 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 128 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 292 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 926 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 266 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 438 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 528 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 634 | 0 | −100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 506 | 139 685 | 1,09 | 36,96 | 55 662 | 5 162 758 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 720 | 138 179 | 1,26 | 25,76 | 44 316 | 3 560 182 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 128 | 136 459 | 0,83 | 30,74 | 34 675 | 4 194 750 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 292 | 135 331 | 1,72 | 28,50 | 65 311 | 3 856 257 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 926 | 133 039 | 1,47 | 19,24 | 37 047 | 2 559 005 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 500 | 131 113 | 1,94 | 25,18 | 62 950 | 3 301 425 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 266 | 128 613 | 0,99 | 31,21 | 39 512 | 4 014 012 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 438 | 127 347 | 1,95 | 24,80 | 60 475 | 3 158 842 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 528 | 124 909 | 3,76 | 29,02 | 131 403 | 3 624 859 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 634 | 120 381 | 2,24 | 27,42 | 72 237 | 3 301 449 | |
2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −11 670 | 11 670 | −50,00 | ||||
2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −5 370 | 117 747 | −4,36 | 112,17 | −602 353 | 13 207 681 | |
2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 11 670 | 123 117 | 10,47 | ||||
2015-12-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 8 929 | 8 929 | |||||
2015-11-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
2015-07-29 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3 500 | 3 500 | |||||
2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 625 | 8 625 | |||||
2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −11 200 | 0 | −100,00 | ||||
2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −5 154 | 111 447 | −4,42 | 108,06 | −556 941 | 12 042 963 | |
2015-05-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 11 200 | 116 601 | 10,63 | ||||
2015-03-03 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −8 334 | 0 | −100,00 | ||||
2015-03-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −4 078 | 105 401 | −3,72 | 121,53 | −495 599 | 12 809 384 | |
2015-03-03 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8 334 | 109 479 | 8,24 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 640 | 13 124 | −11,11 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 478 | 11 824 | −11,11 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 478 | 11 824 | −11,11 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 478 | 11 824 | −11,11 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 478 | 17 738 | −7,69 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 040 | 10 468 | −9,04 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 040 | 10 468 | −9,04 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 375 | 17 500 | −20,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 081 | 8 326 | −20,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 081 | 8 326 | −20,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 562 | 8 290 | −15,85 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −430 | 0 | −100,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −430 | 0 | −100,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −5 333 | 0 | −100,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −860 | 0 | −100,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −148 | 0 | −100,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −573 | 0 | −100,00 | ||||
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 640 | 101 145 | 1,65 | 81,56 | 133 750 | 8 248 880 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 99 505 | 1,51 | 78,12 | 115 454 | 7 772 833 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 98 027 | 1,53 | 71,33 | 105 426 | 6 992 266 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 96 549 | 1,55 | 59,24 | 87 549 | 5 719 080 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 040 | 95 071 | 1,11 | 49,48 | 51 454 | 4 703 638 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 375 | 94 031 | 4,88 | 40,22 | 175 962 | 3 781 927 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 081 | 89 656 | 2,38 | 36,68 | 76 321 | 3 288 134 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 081 | 87 575 | 2,43 | 34,70 | 72 211 | 3 038 852 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 040 | 85 494 | 1,23 | 36,46 | 37 924 | 3 117 539 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 562 | 84 454 | 1,88 | 36,96 | 57 732 | 3 121 420 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 430 | 82 892 | 0,52 | 25,76 | 11 079 | 2 135 712 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 333 | 82 462 | 6,91 | 29,75 | 158 657 | 2 453 244 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 860 | 77 129 | 1,13 | 28,94 | 24 888 | 2 232 113 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 430 | 76 269 | 0,57 | 26,17 | 11 253 | 1 995 960 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 148 | 75 839 | 0,20 | 30,74 | 4 550 | 2 331 291 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 478 | 75 691 | 1,99 | 74,30 | 109 815 | 5 623 841 | |
2015-02-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 573 | 74 213 | 0,78 | 27,28 | 15 629 | 2 024 160 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 434 | 13 302 | −25,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 434 | 13 302 | −25,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 434 | 13 302 | −25,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 434 | 19 216 | −18,75 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −3 122 | 11 508 | −21,34 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −3 122 | 11 508 | −21,34 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −13 125 | 21 875 | −37,50 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −6 243 | 10 407 | −37,50 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −6 243 | 10 407 | −37,50 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 688 | 9 852 | −32,24 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 290 | 430 | −75,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 290 | 430 | −75,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −41 335 | 5 333 | −88,57 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 580 | 860 | −75,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −444 | 148 | −75,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 719 | 573 | −75,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 922 | 14 764 | −25,00 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −13 666 | 73 640 | −15,65 | 118,75 | −1 622 838 | 8 744 750 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 30 404 | 87 306 | 53,43 | ||||
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | −117 099 | 56 902 | −67,30 | 120,68 | −14 131 156 | 6 866 763 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 174 001 | 2,61 | 78,12 | 346 362 | 13 592 088 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 169 567 | 2,69 | 71,33 | 316 277 | 12 095 214 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 165 133 | 2,76 | 59,24 | 262 648 | 9 781 653 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 122 | 160 699 | 1,98 | 49,48 | 154 461 | 7 950 583 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 13 125 | 157 577 | 9,09 | 40,22 | 527 888 | 6 337 747 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 243 | 144 452 | 4,52 | 36,68 | 228 962 | 5 297 777 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6 243 | 138 209 | 4,73 | 34,70 | 216 632 | 4 795 852 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 122 | 131 966 | 2,42 | 36,46 | 113 844 | 4 812 140 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 688 | 128 844 | 3,78 | 36,96 | 173 268 | 4 762 074 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 290 | 124 156 | 1,05 | 25,76 | 33 237 | 3 198 879 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 41 335 | 122 866 | 50,70 | 29,75 | 1 229 716 | 3 655 264 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 580 | 81 531 | 3,27 | 28,94 | 74 665 | 2 359 507 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 290 | 78 951 | 1,66 | 26,17 | 33 759 | 2 066 148 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 444 | 77 661 | 0,58 | 30,74 | 13 649 | 2 387 299 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 719 | 77 217 | 2,28 | 27,28 | 46 886 | 2 106 094 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 434 | 75 498 | 6,24 | 74,30 | 329 446 | 5 609 501 | |
2015-02-10 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 922 | 71 064 | 7,44 | 81,56 | 401 414 | 5 795 625 | |
2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10 175 | 10 175 | |||||
2014-12-23 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4 550 | 4 550 | |||||
2014-12-23 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 15 670 | 15 670 | |||||
2014-10-29 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10 175 | 10 175 | |||||
2014-07-29 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4 200 | 4 200 | |||||
2014-07-29 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 20 350 | 20 350 | |||||
2014-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −6 837 | 33 071 | −17,13 | 160,54 | −1 097 612 | 5 309 218 | |
2014-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
A - Award | 15 188 | 39 908 | 61,44 | ||||
2014-02-05 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
2013-12-31 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −7 777 | 0 | −100,00 | ||||
2013-12-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −3 501 | 24 720 | −12,41 | 168,93 | −591 424 | 4 175 950 | |
2013-12-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 777 | 28 221 | 38,04 | ||||
2013-12-04 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3 280 | 3 280 | |||||
2013-12-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
2013-11-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2013-11-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −4 502 | 20 444 | −18,05 | 151,30 | −681 175 | 3 093 279 | |
2013-11-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 10 000 | 24 946 | 66,91 | ||||
2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −7 500 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | −5 000 | 14 946 | −25,07 | 146,47 | −732 335 | 2 189 096 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 500 | 19 946 | 60,26 | 62,35 | 467 625 | 1 243 633 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7 500 | 12 446 | 151,64 | 70,63 | 529 725 | 879 061 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 081 | 6 244 | −25,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −3 125 | 7 270 | −30,06 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 718 | 860 | −66,64 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 718 | 860 | −66,64 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −23 333 | 23 334 | −50,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 577 | 860 | −74,98 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 577 | 860 | −74,98 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −3 438 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −3 438 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −3 437 | 1 146 | −74,99 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 583 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −17 787 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −2 392 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 219 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −4 875 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −3 657 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −1 393 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | −558 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | −96 406 | 4 946 | −95,12 | 147,01 | −14 172 646 | 727 111 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 081 | 101 352 | 2,10 | 72,93 | 151 767 | 7 391 601 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 125 | 99 271 | 3,25 | 73,92 | 231 000 | 7 338 112 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 718 | 96 146 | 1,82 | 51,53 | 88 529 | 4 954 403 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 23 333 | 94 428 | 32,82 | 59,50 | 1 388 314 | 5 618 466 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 718 | 71 095 | 2,48 | 57,88 | 99 438 | 4 114 979 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 577 | 69 377 | 3,86 | 52,34 | 134 880 | 3 631 192 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 577 | 66 800 | 4,01 | 61,48 | 158 434 | 4 106 864 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 438 | 64 223 | 5,66 | 56,99 | 195 932 | 3 660 069 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 437 | 60 785 | 5,99 | 54,55 | 187 488 | 3 315 822 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 583 | 57 348 | 8,69 | 46,02 | 210 910 | 2 639 155 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 438 | 52 765 | 6,97 | 39,01 | 134 116 | 2 058 363 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 17 787 | 49 327 | 56,40 | 38,47 | 684 266 | 1 897 610 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 500 | 31 540 | 8,61 | 50,36 | 125 900 | 1 588 354 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 000 | 29 040 | 20,80 | 57,80 | 289 000 | 1 678 512 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5 000 | 24 040 | 26,26 | 71,82 | 359 100 | 1 726 553 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2 392 | 19 040 | 14,37 | 62,42 | 149 309 | 1 188 477 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 219 | 16 648 | 7,90 | 49,61 | 60 475 | 825 907 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 875 | 15 429 | 46,19 | 73,55 | 358 556 | 1 134 803 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 657 | 10 554 | 53,02 | 58,53 | 214 044 | 617 726 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1 393 | 6 897 | 25,31 | 58,04 | 80 850 | 400 302 | |
2013-08-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 558 | 5 504 | 11,28 | 54,85 | 30 606 | 301 894 | |
2013-07-31 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
2013-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 500 | 5 500 | |||||
2013-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11 825 | 11 825 | |||||
2013-04-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −4 583 | 0 | −100,00 | ||||
2013-04-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −1 791 | 4 946 | −26,58 | 123,00 | −220 293 | 608 358 | |
2013-04-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4 583 | 6 737 | 212,77 | ||||
2013-01-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 325 | 8 325 | |||||
2012-12-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 835 | 5 835 | |||||
2012-12-19 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2012-11-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (Right to Buy) |
A - Award | 8 325 | 8 325 | |||||
2012-08-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 325 | 8 325 | |||||
2012-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 5 600 | 5 600 | |||||
2012-05-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 8 325 | 8 325 | |||||
2012-04-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | −3 056 | 0 | −100,00 | ||||
2012-04-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
F - Taxes | −902 | 2 154 | −29,52 | 78,32 | −70 645 | 168 701 | |
2012-04-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3 056 | 3 056 | |||||
2012-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Units |
A - Award | 4 167 | 4 167 | |||||
2012-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Stock options (right to buy) |
A - Award | 12 500 | 12 500 | |||||
2012-02-24 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
2 409 |